#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Muscular dystrophy Neurodegenerative disorder Skin angiosarcoma Gastrointestinal neuroendocrine tumour Cutaneous T-cell lymphoma stage II Primary immunodeficiency syndrome Antiphospholipid antibodies Pyoderma gangrenosum Bronchiolitis Myocarditis Heavy menstrual bleeding Acute myeloid leukaemia recurrent Neonatal alloimmune thrombocytopenia Small intestine adenocarcinoma More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Life with Disease Ocular melanoma – Diagnostics Chordoma – Treatment Angelman’s syndrome Chondrosarcoma metastatic – Basic Information Alveolar rhabdomyosarcoma – Treatment Lennox-Gastaut syndrome – Basic Information Progressive supranuclear palsy – Diagnostics Wiskott-Aldrich syndrome – Treatment MELAS syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000017033 Siponimod Xxb750 Ciclesonide Gentamicin IBANDRONIC ACID AUROCELL-TX Envudeucitinib Sisunatovir Ttx-030 ORX750 Capsaicin Bms-986449-03 AZD5148 VG801-1 Sebetralstat Biotin Ginisortamab Cladribine Ly3541860 More therapies…

    Learn about Your Condition

    Ocular lymphoma Biliary adenoma Hyperparathyroidism secondary Stress urinary incontinence Somatic symptom disorder Colitis Neuromuscular scoliosis Chondrocalcinosis Constipation Malignant oligodendroglioma Cardiac disorder Type 1 diabetes mellitus Langerhans cell sarcoma Bone sarcoma Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Metoclopramide Hydrochloride Anhydrous
    • Palonosetron Hydrochloride
    Belgium The Netherlands Norway Sweden

  • Study on Preventing Blood Clots in Patients with Advanced Germ Cell Tumors Using Cisplatin and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular germ cell tumour
    Investigated Drugs:
    • Tinzaparin Sodium
    • Dalteparin Sodium
    • Enoxaparin Sodium
    France

  • Study of ONC201 for Patients with Newly Diagnosed H3 K27M-mutant Diffuse Glioma After Radiotherapy

    Recruiting

    3 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    Austria Denmark Germany Italy The Netherlands Spain

  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    • Marstacimab
    Austria Czechia Denmark France Germany Italy +2

  • Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

    Recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium Czechia France Germany Hungary +3

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
Previous Page
1 … 582 583 584 585 586 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!